Literature DB >> 12473400

Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors.

Charles H Adler1, Joseph G Hentz, Jeffrey N Joyce, Thomas Beach, John N Caviness.   

Abstract

This study presents data on the antemortem evaluations of a cohort of individuals registered in a brain donation program. Clinical evaluation determined that many individuals were unaware they had clinical signs of Parkinson's disease (PD) (rest tremor, bradykinesia, rigidity). Quantitative motor testing (timed tapping test and Purdue pegboard test) revealed a graded reduction in performance in those clinically found to have clinically possible and clinically probable PD. Longitudinal examinations over 4 years revealed some individuals progressed from control to clinically possible PD and clinically possible PD to clinically probable PD. This study underscores the importance of longitudinal antemortem testing of prospective brain donors as well as the potential value of quantitative motor testing.

Entities:  

Mesh:

Year:  2002        PMID: 12473400     DOI: 10.1016/s1353-8020(02)00012-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

1.  Quantitative EEG as a predictive biomarker for Parkinson disease dementia.

Authors:  B T Klassen; J G Hentz; H A Shill; E Driver-Dunckley; V G H Evidente; M N Sabbagh; C H Adler; J N Caviness
Journal:  Neurology       Date:  2011-06-01       Impact factor: 9.910

2.  Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease.

Authors:  Anne Damian; Charles H Adler; Joseph G Hentz; Holly A Shill; John N Caviness; Marwan N Sabbagh; Virgilio G H Evidente; Thomas G Beach; Erika Driver-Dunckley
Journal:  Parkinsonism Relat Disord       Date:  2012-07-06       Impact factor: 4.891

3.  Incidental Lewy body disease: clinical comparison to a control cohort.

Authors:  Charles H Adler; Donald J Connor; Joseph G Hentz; Marwan N Sabbagh; John N Caviness; Holly A Shill; Brie Noble; Thomas G Beach
Journal:  Mov Disord       Date:  2010-04-15       Impact factor: 10.338

4.  Aged monkeys as a partial model for Parkinson's disease.

Authors:  P J Hurley; J D Elsworth; M C Whittaker; R H Roth; D E Redmond
Journal:  Pharmacol Biochem Behav       Date:  2011-05-18       Impact factor: 3.533

5.  Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathies.

Authors:  Lih-Fen Lue; Douglas G Walker; Charles H Adler; Holly Shill; Hung Tran; Haruhiko Akiyama; Lucia I Sue; John Caviness; Marwan N Sabbagh; Thomas G Beach
Journal:  Brain Pathol       Date:  2012-04-12       Impact factor: 6.508

6.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

Authors:  Jonathan Wills; Jessica Jones; Thomas Haggerty; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  Exp Neurol       Date:  2010-06-28       Impact factor: 5.330

7.  Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders.

Authors:  John N Caviness; Charles H Adler; Joseph G Hentz; Holly A Shill; Virgilio G H Evidente; Erika D Driver-Dunckley; Marwan N Sabbagh; Lucia Sue; Thomas G Beach
Journal:  Clin Neurophysiol       Date:  2011-05-26       Impact factor: 3.708

8.  Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome.

Authors:  Charles H Adler; Joseph G Hentz; Holly A Shill; Marwan N Sabbagh; Erika Driver-Dunckley; Virgilio G H Evidente; Sandra A Jacobson; Thomas G Beach; Bradley Boeve; John N Caviness
Journal:  Parkinsonism Relat Disord       Date:  2011-04-08       Impact factor: 4.891

9.  Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment.

Authors:  Charles H Adler; John N Caviness; Marwan N Sabbagh; Holly A Shill; Donald J Connor; Lucia Sue; Virgilio G H Evidente; Erika Driver-Dunckley; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2010-09-14       Impact factor: 17.088

10.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.